Trump Proposes Tariffs on Imported Generic Drugs, Impact Uncertain
President Donald Trump has proposed tariffs of up to 200% on imported generic drugs after a two-year grace period intended to encourage domestic manufacturing. Analysts suggest that companies with existing U.S.-based production may be better positioned for the change; however, thin profit margins and unclear policy details complicate predictions about market impact.
Topics: generic drugs pharmaceuticals trade policy U.S. manufacturing